Recent advances in the medical management of Takayasu arteritis: an update on use of biologic therapies

A Clifford, GS Hoffman - Current opinion in rheumatology, 2014 - journals.lww.com
Anti-TNF agents are recommended for the treatment of Takayasu's patients who are unable
to taper prednisone despite treatment with a nonbiologic immunosuppressive medication …
被引用次数：126 相关文章

[引用][C] Recent advances in the medical management of Takayasu arteritis

A Clifford, GS Hoffman - Current Opinion in Rheumatology, 2014 - cir.nii.ac.jp
Recent advances in the medical management of Takayasu arteritis | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

Recent advances in the medical management of Takayasu arteritis: an update on use of biologic therapies

A Clifford, GS Hoffman - Current opinion in rheumatology, 2014 - pubmed.ncbi.nlm.nih.gov
Purpose of review To critically review recent advances in medical management of Takayasu
arteritis, with a special focus on the rationale and evidence to support the use of biologic …

Recent advances in the medical management of Takayasu arteritis: an update on use of biologic therapies.

A Clifford, GS Hoffman - Current Opinion in Rheumatology, 2014 - europepmc.org
Anti-TNF agents are recommended for the treatment of Takayasu's patients who are unable
to taper prednisone despite treatment with a nonbiologic immunosuppressive medication …